Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer

NCT04159142 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

414

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer
Nab-paclitaxel

Interventions

DRUG: Nab-paclitaxel + Carboplatin
DRUG: Nab-paclitaxel + Capecitabine

Sponsor

Hebei Medical University Fourth Hospital

Collaborators

[object Object]
[object Object]